CrkL is a Co-Activator of Estrogen Receptor α That Enhances Tumorigenic Potential in Cancer

Authors

Keywords

Journal

Volume 25, Issue 9, Pages 1499-1512

Publisher

The Endocrine Society

Online

2011-06-24

DOI

10.1210/me.2011-0008

Discuss science. Find collaborators. Network.

Join a conversation

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started